Curt A. Ries, MD

Professor, Department of Medicine (Hematology/Oncology), UCSF

Phone: (415) 353-2421 (appts)
Box 0324, UCSF
San Francisco, CA 94143-0324

View on UCSF Profiles

Additional Websites

• Physician Referral Directory

Education

Johns Hopkins University, 1957-1960, Biological Sciences
University of Rochester School of Medicine, M.D., 1960-1964, Medicine

Professional Experience

• 1964-1965
  Intern in Medicine, Strong Memorial Hospital, Rochester, NY
• 1965-1966
  Assistant Resident in Medicine, Strong Memorial Hospital, Rochester, NY
• 1968-1969
  Resident in Medicine (II), University of California Hospitals, San Francisco, CA
• 1969-1970
  Chief Resident in Medicine, University of California Hospitals (San Francisco General Hospital), San Francisco, CA
• 1970-1972
  Fellow in Hematology, University of California, San Francisco, CA
• 1972-1976
  Assistant Clinical Professor of Medicine, Laboratory Medicine, and Radiology (Nuclear Medicine), University of California, San Francisco, CA
• 1972-1974
  Chief, Hematology Clinic, University of California Medical Center, San Francisco, CA
• 1974-1980
  Director, Hematology & Oncology Clinics, University of California Medical Center, San Francisco, CA
• 1976-1983
  Associate Clinical Professor of Medicine and Laboratory Medicine, University of California, San Francisco, CA
• 1989-1991
  Director, Adult Bone Marrow Transplant Program, University of California Medical Center, San Francisco, CA
• 1975-2002
  Director, Outpatient Transfusion Service, University of California Medical Center, San Francisco, CA
• 1980-2002
  Director, Hematology/Oncology Faculty Practice, University of California Medical Center, San Francisco, CA
• 1983-2003
  Clinical Professor of Medicine, University of California, San Francisco, CA
• 2003-present
  Clinical Professor of Medicine Emeritus, University of California, San Francisco, CA

Selected Publications

1. Damon L, Rugo H, Tolaney S, Navarro W, Martin T, Ries C, Case D, Ault K, Linker C. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim. Biol Blood Marrow Transplant. 2006 Mar; 12(3):316-24.
   View on PubMed
2. Damon LE, Johnston LJ, Ries CA, Rugo HS, Case D, Ault K, Linker CA. Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Cancer Chemother Pharmacol. 2004 Jun; 53(6):468-74.
   View on PubMed
3. Gunn N, Damon L, Varosy P, Navarro W, Martin T, Ries C, Linker C. High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia. Biol Blood Marrow Transplant. 2003 Oct; 9(10):643-8.
   View on PubMed
4. Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol. 2002 May 15; 20(10):2464-71.
   View on PubMed
5. Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL. Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone Marrow Transplant. 2002 Feb; 29(4):297-301.
   View on PubMed
6. Damon LE, Wolf JL, Rugo HS, Gold E, Zander AR, Cassidy M, Cecchi G, Cohen N, Irwin D, Tracy M, Ries CA, Linker CA. High-dose chemotherapy (CTM) for breast cancer. Bone Marrow Transplant. 2000 Aug; 26(3):257-68.
   View on PubMed
7. Linker CA, Ries CA, Damon LE, Sayre P, Navarro W, Rugo HS, Rubin A, Case D, Crilley P, Topolsky D, Brodsky I, Zamkoff K, Wolfe JL. Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biol Blood Marrow Transplant. 2000; 6(1):50-7.
   View on PubMed
8. Ries C, Loher F, Zang C, Ismair MG, Petrides PE. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Cancer Res. 1999 May; 5(5):1115-24.
   View on PubMed
9. Ware LB, Keith FM, Gordon RL, Ries CA, Seitz RF, Gold WM, Golden JA. Lung transplantation for pulmonary amyloidosis: a case report. J Heart Lung Transplant. 1998 Nov; 17(11):1129-32.
   View on PubMed
10. Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone Marrow Transplant. 1998 Nov; 22(9):865-72.
    View on PubMed
11. Feldman EJ, Seiter K, Damon L, Linker C, Rugo H, Ries C, Case DC, Beer M, Ahmed T. A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia. Leukemia. 1997 Apr; 11(4):485-9.
    View on PubMed
12. Smith GA, Damon LE, Rugo HS, Ries CA, Linker CA. High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol. 1997 Feb; 15(2):833-9.
    View on PubMed
13. Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW. The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation. Endoscopy. 1996 Oct; 28(8):680-5.
    View on PubMed
14. Damon LE, Rugo HS, Ries CA, Linker CA. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia. Bone Marrow Transplant. 1996 Jan; 17(1):93-9.
    View on PubMed
15. Damon LE, Rugo HS, Ries CA, Linker CA. Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia. Leukemia. 1994 Apr; 8(4):535-41.
    View on PubMed
16. Rugo HS, Damon LE, Ries CA, Wolf JL, Linker CA. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma. Prog Clin Biol Res. 1994; 389:505-11.
    View on PubMed
17. Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update. Semin Oncol. 1993 Aug; 20(4 Suppl 4):40-8; quiz 49.
    View on PubMed
18. Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. Blood. 1993 Jan 15; 81(2):311-8.
    View on PubMed
19. Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood. 1992 Oct 15; 80(8):1890-5.
    View on PubMed
20. Linker CA, Levitt LJ, O'Donnell M, Forman SJ, Ries CA. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood. 1991 Dec 1; 78(11):2814-22.
    View on PubMed

View on UCSF Profiles